Clinical trials with semaglutide have demonstrated significant potential to treat diseases of the brain, liver, heart, vascular system (veins and arteries), lungs, bones, skin, and kidneys [1,4], and this class of drugs also shows promise for treating arthritis [1,5]
Efficacy should be hedged accordingly the trials tell us what the drug does in a controlled trial population, not what any individual using research material will experience
Contact the experienced Chicago personal injury lawyers from TorHoerman Law for a free, no-obligation Chicago personal injury lawsuit case consultation today
Mean Changes in Anthropometry and Cardiometabolic Parameters at Week 68 in Study 6 in East-Asian Patients with WEGOVY Injection Missing data were imputed from retrieved subjects of the same randomized treatment arm (RD-MI)
Until bellwether trials have been ordered and reach their conclusion, plaintiffs in the case remain a long way away from receiving any sort of compensation